Citation Impact
Citing Papers
Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2
2011 Standout
Glucagon-like peptide-1: a potent regulator of food intake in humans
1999
Effect of vanilloid drugs on gastrointestinal transit in mice
2001
Pharmacological Actions of Cannabinoids
2005
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*
2003 Standout
Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves
1995
Microbial tryptophan catabolites in health and disease
2018 Standout
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
Melatonin and ulcerative colitis: Evidence, biological mechanisms, and future research
2008
Black Pepper and its Pungent Principle-Piperine: A Review of Diverse Physiological Effects
2007 Standout
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
The biology of incretin hormones
2006 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Biological actions and therapeutic potential of the glucagon-like peptides
2002
Distribution, function and physiological role of melatonin in the lower gut
2011
Irritable bowel syndrome
2016 Standout
Synergy research: Approaching a new generation of phytopharmaceuticals
2009
Management of functional somatic syndromes
2007
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Capsaicin‐sensitive vagal stimulation‐induced gastric acid secretion in the rat: evidence for cholinergic vagal afferents
1991
Biology of Incretins: GLP-1 and GIP
2007 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Binding of STW 5 (Iberogast®) and its components to intestinal 5-HT, muscarinic M3, and opioid receptors
2006
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
How were new medicines discovered?
2011 Standout
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
2003
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Cannabinoids and the Digestive Tract
2005
Differential chemosensory function and receptor expression of splanchnic and pelvic colonic afferents in mice
2005
The Physiology of Glucagon-like Peptide 1
2007 Standout
Opioid-Induced Bowel Dysfunction
2003
Tendon Injury and Tendinopathy
2005 Standout
Discovery and resupply of pharmacologically active plant-derived natural products: A review
2015 Standout
The endogenous cannabinoid system protects against colonic inflammation
2004
Exendin-4 and exendin-(9–39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7–36)NH2
1994
Cannabinoids and the gut: New developments and emerging concepts
2010
Effects of Cannabinoids on Neurotransmission
2005
REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance
2002 Standout
Synergy research: Approaching a new generation of phytopharmaceuticals
2010
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Vanilloid (Capsaicin) Receptors and Mechanisms
1999 Standout
Antimicrobial Activity of Some Essential Oils—Present Status and Future Perspectives
2017 Standout
The endogenous cannabinoid system protects against colonic inflammation
2004
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
The Glucagon-Like Peptides
1999
Opioid Complications and Side Effects
2008 Standout
Chronic Inflammation and Cytokines in the Tumor Microenvironment
2014 Standout
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice
2011 StandoutNobel
Works of H.D. Allescher being referenced
Modulatory effect of endogenous and exogenous opioids on the excitatory reflex pathway of the rat ileum
2000
Cannabinoid type 1 receptor modulates intestinal propulsion by an attenuation of intestinal motor responses within the myenteric part of the peristaltic reflex
2007
Effect of naloxone on vagally-induced gastric acid secretion in rats
1988
Effect of cannabinoids on neural transmission in rat gastric fundus
2002
Ascending neural pathways in the rat ileum in vitro — Effect of capsaicin and involvement of nitric oxide
1992
Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon
2004
Functional dyspepsia – A multicausal disease and its therapy
2006
Differential stimulatory effects of cannabinoids on VIP release and NO synthase activity in synaptosomal fractions from rat ileum
2008
Do We Need Gastric Acid?
2008
Treatment of Non-Ulcer Dyspepsia: a Meta-Analysis of Placebo-Controlled Prospective Studies
2001
Inhibition of small conductance K<sup>+</sup>-channels attenuated melatonin-induced relaxation of serotonin-contracted rat gastric fundus
2000
Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding
1994
2006
Inhibition of small conductance K+-channels attenuated melatonin-induced relaxation of serotonin-contracted rat gastric fundus
2000